bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

Author's Avatar
Jan 24, 2023

bioAffinity+Technologies%2C+Inc. (NASDAQ: BIAF; BIAFW) today announced publication of “Detection+of+early-stage+lung+cancer+in+sputum+using+automated+flow+cytometry+and+machine+learning” detailing results of the Company’s clinical trial for its non-invasive diagnostic CyPath%3Csup%3E%26reg%3B%3C%2Fsup%3E+Lung in Respiratory+Research, one of the leading peer-reviewed open access journals in the field of respiratory medicine.